Abstract:
The invention provides microporous polymer films which comprise a halopolymer in which the repeat units are -(C n H 2n )- and -(C m X 2m )-, where each X independently represents fluorine or chlorine and the values of n and m are more than one and less than six. The films of the invention can be suitable for use in high temperature applications and can be substantially inert to certain chemically aggressive substances such as alkali and alkaline earth metals. The films find particular application in electrochemical cells comprising a lithium anode and thionyl chloride electrolyte.
Abstract translation:本发明提供了包含卤代聚合物的微孔聚合物膜,其中重复单元是 - (C n H 2n) - 和 - (C m X 2 m) - ,其中每个X独立地表示氟或氯,并且n和m的值大于1, 小于6。 本发明的膜可以适用于高温应用,对某些化学腐蚀性物质如碱金属和碱土金属基本上是惰性的。 该电影特别适用于包含锂阳极和亚硫酰氯电解质的电化学电池。
Abstract:
Compositions for forming porous materials and three-dimensional objects, including fibers, films and coatings made from the materials are provided. Also provided are methods for forming the porous objects from the compositions. The compositions include a solvent, a polymer binder that is soluble in the solvent, and solid particles that are insoluble in the solvent. The solid particles include water-soluble salt particles that can be selectively dissolved from objects made from the compositions to render the resulting structures porous.
Abstract:
Provided herein are materials and methods of reducing contamination in a biological substance or treating contamination in a subject by one or more toxins comprising contacting the biological substance with an effective amount of a sorbent capable of sorbing the toxin, wherein the sorbent comprises a plurality of pores ranging from 50 Å to 40,000 Å with a pore volume of 0.5 cc/g to 5.0 cc/g and a size of 0.05 mm to 2 cm and sorbing the toxin. Also provided are kits to reduce contamination by one or more toxins in a biological substance comprising a sorbent capable of sorbing a toxin, wherein the sorbent comprises a plurality of pores ranging from 50 Å to 40,000 Å with a pore volume of 0.5 cc/g to 5.0 cc/g and a size of 0.05 mm to 2 cm and a vessel to store said sorbent when not in use together with packaging for same.
Abstract:
The present invention concerns methods of treating systemic, regional, or local inflammation from a patient suffering or at risk of inflammation comprising administration of a therapeutically effective dose of a sorbent that sorbs an inflammatory mediator in said patient. In some preferred embodiments, the sorbent is a biocompatible organic polymer.
Abstract:
The present invention relates to a method for preparing a polyurethane synthetic leather having uniform fine pores therein, by coagulating a polyurethane mixture solution prepared by mixing an additive containing sucrose with a polyurethane resin composition, and then removing the additive in the coagulated polyurethane mixture solution. The present invention can not only form a smooth surface after a sanding process but also improve an air permeability and softness due to fine pores formed in the polyurethane synthetic leather.In addition, the size and density of the fine pores can be optionally adjusted by adjusting the content of the additive, and the present invention can provide various types of synthetic leathers depending on the product use.
Abstract:
A method for preparing a porous fluoropolymer precursor includes combining a fluoropolymer and a removable additive to form a composition, the removable additive having a thermal decomposition temperature greater than a sintering temperature of the fluoropolymer, compressing the composition to form a preform, and sintering the preform to form the porous fluoropolymer precursor. A method for preparing a porous fluoropolymer includes disposing the porous fluoropolymer precursor in a removing agent, contacting the removable additive with the removing agent, and removing, by the removing agent, the removable additive from the porous fluoropolymer precursor to form the porous fluoropolymer, wherein the porous fluoropolymer comprises a plurality of pores formed by removing the removable additive
Abstract:
The present invention includes compositions, methods, systems of making a composition that includes one or more active agent; a recognitive polymeric matrix; and a porosigen, wherein the composition comprises a porous recognitive, swellable hydrogel that dissociates under conditions of low water or humidity.
Abstract:
The present invention provides a resinous porous article having a high interconnected hole porosity and capable of retaining a large amount of a lubricating oil and does not rust iron and steel, even though an unextracted portion of a pore-forming substance bleeds out when the resinous porous article is used as parts which contact a metal portion or the like and a method of producing the resinous porous article. The resinous porous article is formed by a producing method of molding a resin containing the pore-forming substance into a molding, and extracting the pore-forming substance from the molding with a solvent which does not dissolve the resin therein. The resinous porous article has an interconnected hole porosity not less than 30%. The pore-forming substance consists of an alkali compound.
Abstract:
Devices formed of or including biocompatible polyhydroxyalkanoates are provided with controlled degradation rates, preferably less than one year under physiological conditions. Preferred devices include sutures, suture fasteners, meniscus repair devices, rivets, tacks, staples, screws (including interference screws), bone plates and bone plating systems, surgical mesh, repair patches, slings, cardiovascular patches, orthopedic pins (including bone filling augmentation material), adhesion barriers, stents, guided tissue repair/regeneration devices, articular cartilage repair devices, nerve guides, tendon repair devices, atrial septal defect repair devices, pericardial patches, bulking and filling agents, vein valves, bone marrow scaffolds, meniscus regeneration devices, ligament and tendon grafts, ocular cell implants, spinal fusion cages, skin substitutes, dural substitutes, bone graft substitutes, bone dowels, wound dressings, and hemostats. The polyhydroxyalkanoates can contain additives, be formed of mixtures of monomers or include pendant groups or modifications in their backbones, or can be chemically modified, all to alter the degradation rates. The polyhydroxyalkanoate compositions also provide favorable mechanical properties, biocompatibility, and degradation times within desirable time frames under physiological conditions.
Abstract:
The present invention provides for concentrated aqueous silk fibroin solutions and an all-aqueous mode for preparation of concentrated aqueous fibroin solutions that avoids the use of organic solvents, direct additives, or harsh chemicals. The invention further provides for the use of these solutions in production of materials, e.g., fibers, films, foams, meshes, scaffolds and hydrogels.